All In Biotech

Drug Trial Radar · NCT04323098

Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

A Phase 3b, Single Arm, Open-Label Study to Evaluate the Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII, With Prophylactic Corticosteroids in Hemophilia A Patients

Last checked: Nov 20, 2026Latest source record: Oct 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

22

Actual

Start

Dec 8, 2020

Primary completion

Jan 27, 2023

Study completion May 8, 2025

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Mar 26, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase III clinical study will evaluate the safety and effectiveness of valoctocogene roxaparvovec in combination with prophylactic corticosteroids in patients with severe hemophilia A.

Conditions

  • Hemophilia A

Interventions

  • valoctocogene roxaparvovecBiological

    Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in FVIII Activity as Measured by Chromogenic Substrate Assay at Week 52.Time frame: Baseline to Week 52

Locations

12 sites in 4 countries. Site status is shown where the registry gives one.

  • University of California Davis Health

    Sacramento, California

  • Washington University School of Medicine

    St Louis, Missouri

  • Nationwide Children's Hospital

    Columbus, Ohio

  • The Royal Adelaide Hospital

    Adelaide, Australia

  • Royal Brisbane and Women's Hospital

    Brisbane, Australia

  • Alfred Hospital

    Melbourne, Australia

  • Fiona Stanley Hospital

    Perth, Australia

  • Royal Prince Alfred Hospital

    Sydney, Australia

  • Campinas University Clinical Hospital

    Campinas, Brazil

  • Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

    São Paulo, Brazil

  • Changhua Christian Medical Foundation Changhua Christian Hospital

    Changhua, Taiwan

  • Taichung Veterans General Hospital

    Taichung, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.